| Anniston Careplus, Llc | |
|
700 Quintard Ave Anniston AL 36201-5758 | |
| (256) 236-9400 | |
| Not Available |
| Full Name | Anniston Careplus, Llc |
|---|---|
| Speciality | Family Medicine |
| Location | 700 Quintard Ave, Anniston, Alabama |
| Authorized Official Name and Position | Angela D Vaughn (ADMINISTRATOR) |
| Authorized Official Contact | 2563104941 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Anniston Careplus, Llc 700 Quintard Ave Anniston AL 36201-5758 Ph: (256) 236-9400 | Anniston Careplus, Llc 700 Quintard Ave Anniston AL 36201-5758 Ph: (256) 236-9400 |
| NPI Number | 1295275139 |
|---|---|
| Provider Enumeration Date | 02/25/2017 |
| Last Update Date | 02/25/2017 |
| Medicare PECOS PAC ID | 0648557801 |
|---|---|
| Medicare Enrollment ID | O20170426001461 |
News Archive
"Christoph Benn, director of resource mobilization and donor relations at the Global Fund to Fight AIDS, Tuberculosis and Malaria, updated global health community advocates Wednesday on ... the multilateral organization," the Center for Global Health Policy's "Science Speaks" blog reports.
An "invisible turning point" in the fight against HIV/AIDS recently occurred: "the realisation that simply strengthening the vertical programme that is AIDS has to end. The new opportunity is integration," a Lancet editorial states.
DNA repair is essential for cell vitality, cell survival and cancer prevention, yet cells' ability to patch up damaged DNA declines with age for reasons not fully understood.
Ever get a flu shot and still get the flu? If so, there's new hope for flu-free winters in the years to come thanks to a new discovery by researchers who found that a drug called DMXAA, originally developed as anti-tumor agent, enhances the ability of flu vaccines to ward off this deadly virus.
Presage Biosciences, a leader in identifying clinically viable oncology drug combinations, today announced that it has entered into a cancer research agreement with Millennium: The Takeda Oncology Company.
› Verified 3 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1295275139 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | (* (Not Available)) | Primary |
| Provider Name | Summer M Phelps |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1689890337 PECOS PAC ID: 6608882881 Enrollment ID: I20060224000432 |
News Archive
"Christoph Benn, director of resource mobilization and donor relations at the Global Fund to Fight AIDS, Tuberculosis and Malaria, updated global health community advocates Wednesday on ... the multilateral organization," the Center for Global Health Policy's "Science Speaks" blog reports.
An "invisible turning point" in the fight against HIV/AIDS recently occurred: "the realisation that simply strengthening the vertical programme that is AIDS has to end. The new opportunity is integration," a Lancet editorial states.
DNA repair is essential for cell vitality, cell survival and cancer prevention, yet cells' ability to patch up damaged DNA declines with age for reasons not fully understood.
Ever get a flu shot and still get the flu? If so, there's new hope for flu-free winters in the years to come thanks to a new discovery by researchers who found that a drug called DMXAA, originally developed as anti-tumor agent, enhances the ability of flu vaccines to ward off this deadly virus.
Presage Biosciences, a leader in identifying clinically viable oncology drug combinations, today announced that it has entered into a cancer research agreement with Millennium: The Takeda Oncology Company.
› Verified 3 days ago
| Provider Name | Kimberly L Buckalew |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1013189398 PECOS PAC ID: 4789758913 Enrollment ID: I20080805000767 |
News Archive
"Christoph Benn, director of resource mobilization and donor relations at the Global Fund to Fight AIDS, Tuberculosis and Malaria, updated global health community advocates Wednesday on ... the multilateral organization," the Center for Global Health Policy's "Science Speaks" blog reports.
An "invisible turning point" in the fight against HIV/AIDS recently occurred: "the realisation that simply strengthening the vertical programme that is AIDS has to end. The new opportunity is integration," a Lancet editorial states.
DNA repair is essential for cell vitality, cell survival and cancer prevention, yet cells' ability to patch up damaged DNA declines with age for reasons not fully understood.
Ever get a flu shot and still get the flu? If so, there's new hope for flu-free winters in the years to come thanks to a new discovery by researchers who found that a drug called DMXAA, originally developed as anti-tumor agent, enhances the ability of flu vaccines to ward off this deadly virus.
Presage Biosciences, a leader in identifying clinically viable oncology drug combinations, today announced that it has entered into a cancer research agreement with Millennium: The Takeda Oncology Company.
› Verified 3 days ago
| Provider Name | Howard E Mcveigh |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1356404776 PECOS PAC ID: 7719907732 Enrollment ID: I20090702000572 |
News Archive
"Christoph Benn, director of resource mobilization and donor relations at the Global Fund to Fight AIDS, Tuberculosis and Malaria, updated global health community advocates Wednesday on ... the multilateral organization," the Center for Global Health Policy's "Science Speaks" blog reports.
An "invisible turning point" in the fight against HIV/AIDS recently occurred: "the realisation that simply strengthening the vertical programme that is AIDS has to end. The new opportunity is integration," a Lancet editorial states.
DNA repair is essential for cell vitality, cell survival and cancer prevention, yet cells' ability to patch up damaged DNA declines with age for reasons not fully understood.
Ever get a flu shot and still get the flu? If so, there's new hope for flu-free winters in the years to come thanks to a new discovery by researchers who found that a drug called DMXAA, originally developed as anti-tumor agent, enhances the ability of flu vaccines to ward off this deadly virus.
Presage Biosciences, a leader in identifying clinically viable oncology drug combinations, today announced that it has entered into a cancer research agreement with Millennium: The Takeda Oncology Company.
› Verified 3 days ago
| Provider Name | Benjamin S Favis |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1386781664 PECOS PAC ID: 6305989302 Enrollment ID: I20100129000369 |
News Archive
"Christoph Benn, director of resource mobilization and donor relations at the Global Fund to Fight AIDS, Tuberculosis and Malaria, updated global health community advocates Wednesday on ... the multilateral organization," the Center for Global Health Policy's "Science Speaks" blog reports.
An "invisible turning point" in the fight against HIV/AIDS recently occurred: "the realisation that simply strengthening the vertical programme that is AIDS has to end. The new opportunity is integration," a Lancet editorial states.
DNA repair is essential for cell vitality, cell survival and cancer prevention, yet cells' ability to patch up damaged DNA declines with age for reasons not fully understood.
Ever get a flu shot and still get the flu? If so, there's new hope for flu-free winters in the years to come thanks to a new discovery by researchers who found that a drug called DMXAA, originally developed as anti-tumor agent, enhances the ability of flu vaccines to ward off this deadly virus.
Presage Biosciences, a leader in identifying clinically viable oncology drug combinations, today announced that it has entered into a cancer research agreement with Millennium: The Takeda Oncology Company.
› Verified 3 days ago
| Provider Name | Josiah C Daily |
|---|---|
| Provider Type | Practitioner - Emergency Medicine |
| Provider Identifiers | NPI Number: 1285837377 PECOS PAC ID: 6800931056 Enrollment ID: I20100226000797 |
News Archive
"Christoph Benn, director of resource mobilization and donor relations at the Global Fund to Fight AIDS, Tuberculosis and Malaria, updated global health community advocates Wednesday on ... the multilateral organization," the Center for Global Health Policy's "Science Speaks" blog reports.
An "invisible turning point" in the fight against HIV/AIDS recently occurred: "the realisation that simply strengthening the vertical programme that is AIDS has to end. The new opportunity is integration," a Lancet editorial states.
DNA repair is essential for cell vitality, cell survival and cancer prevention, yet cells' ability to patch up damaged DNA declines with age for reasons not fully understood.
Ever get a flu shot and still get the flu? If so, there's new hope for flu-free winters in the years to come thanks to a new discovery by researchers who found that a drug called DMXAA, originally developed as anti-tumor agent, enhances the ability of flu vaccines to ward off this deadly virus.
Presage Biosciences, a leader in identifying clinically viable oncology drug combinations, today announced that it has entered into a cancer research agreement with Millennium: The Takeda Oncology Company.
› Verified 3 days ago
| Provider Name | Daniel C Burnes |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1487851077 PECOS PAC ID: 6002931623 Enrollment ID: I20100920000130 |
News Archive
"Christoph Benn, director of resource mobilization and donor relations at the Global Fund to Fight AIDS, Tuberculosis and Malaria, updated global health community advocates Wednesday on ... the multilateral organization," the Center for Global Health Policy's "Science Speaks" blog reports.
An "invisible turning point" in the fight against HIV/AIDS recently occurred: "the realisation that simply strengthening the vertical programme that is AIDS has to end. The new opportunity is integration," a Lancet editorial states.
DNA repair is essential for cell vitality, cell survival and cancer prevention, yet cells' ability to patch up damaged DNA declines with age for reasons not fully understood.
Ever get a flu shot and still get the flu? If so, there's new hope for flu-free winters in the years to come thanks to a new discovery by researchers who found that a drug called DMXAA, originally developed as anti-tumor agent, enhances the ability of flu vaccines to ward off this deadly virus.
Presage Biosciences, a leader in identifying clinically viable oncology drug combinations, today announced that it has entered into a cancer research agreement with Millennium: The Takeda Oncology Company.
› Verified 3 days ago
| Provider Name | Sherry K Williams |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1386968170 PECOS PAC ID: 0749472801 Enrollment ID: I20101007000426 |
News Archive
"Christoph Benn, director of resource mobilization and donor relations at the Global Fund to Fight AIDS, Tuberculosis and Malaria, updated global health community advocates Wednesday on ... the multilateral organization," the Center for Global Health Policy's "Science Speaks" blog reports.
An "invisible turning point" in the fight against HIV/AIDS recently occurred: "the realisation that simply strengthening the vertical programme that is AIDS has to end. The new opportunity is integration," a Lancet editorial states.
DNA repair is essential for cell vitality, cell survival and cancer prevention, yet cells' ability to patch up damaged DNA declines with age for reasons not fully understood.
Ever get a flu shot and still get the flu? If so, there's new hope for flu-free winters in the years to come thanks to a new discovery by researchers who found that a drug called DMXAA, originally developed as anti-tumor agent, enhances the ability of flu vaccines to ward off this deadly virus.
Presage Biosciences, a leader in identifying clinically viable oncology drug combinations, today announced that it has entered into a cancer research agreement with Millennium: The Takeda Oncology Company.
› Verified 3 days ago
| Provider Name | Shanda P Cotney |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1255588893 PECOS PAC ID: 2163588088 Enrollment ID: I20110518000535 |
News Archive
"Christoph Benn, director of resource mobilization and donor relations at the Global Fund to Fight AIDS, Tuberculosis and Malaria, updated global health community advocates Wednesday on ... the multilateral organization," the Center for Global Health Policy's "Science Speaks" blog reports.
An "invisible turning point" in the fight against HIV/AIDS recently occurred: "the realisation that simply strengthening the vertical programme that is AIDS has to end. The new opportunity is integration," a Lancet editorial states.
DNA repair is essential for cell vitality, cell survival and cancer prevention, yet cells' ability to patch up damaged DNA declines with age for reasons not fully understood.
Ever get a flu shot and still get the flu? If so, there's new hope for flu-free winters in the years to come thanks to a new discovery by researchers who found that a drug called DMXAA, originally developed as anti-tumor agent, enhances the ability of flu vaccines to ward off this deadly virus.
Presage Biosciences, a leader in identifying clinically viable oncology drug combinations, today announced that it has entered into a cancer research agreement with Millennium: The Takeda Oncology Company.
› Verified 3 days ago
| Provider Name | Hala Shama Mourtada |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1417372509 PECOS PAC ID: 6608099528 Enrollment ID: I20140522000889 |
News Archive
"Christoph Benn, director of resource mobilization and donor relations at the Global Fund to Fight AIDS, Tuberculosis and Malaria, updated global health community advocates Wednesday on ... the multilateral organization," the Center for Global Health Policy's "Science Speaks" blog reports.
An "invisible turning point" in the fight against HIV/AIDS recently occurred: "the realisation that simply strengthening the vertical programme that is AIDS has to end. The new opportunity is integration," a Lancet editorial states.
DNA repair is essential for cell vitality, cell survival and cancer prevention, yet cells' ability to patch up damaged DNA declines with age for reasons not fully understood.
Ever get a flu shot and still get the flu? If so, there's new hope for flu-free winters in the years to come thanks to a new discovery by researchers who found that a drug called DMXAA, originally developed as anti-tumor agent, enhances the ability of flu vaccines to ward off this deadly virus.
Presage Biosciences, a leader in identifying clinically viable oncology drug combinations, today announced that it has entered into a cancer research agreement with Millennium: The Takeda Oncology Company.
› Verified 3 days ago
| Provider Name | Bradley Elliott |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1700267507 PECOS PAC ID: 7315255072 Enrollment ID: I20150929001864 |
News Archive
"Christoph Benn, director of resource mobilization and donor relations at the Global Fund to Fight AIDS, Tuberculosis and Malaria, updated global health community advocates Wednesday on ... the multilateral organization," the Center for Global Health Policy's "Science Speaks" blog reports.
An "invisible turning point" in the fight against HIV/AIDS recently occurred: "the realisation that simply strengthening the vertical programme that is AIDS has to end. The new opportunity is integration," a Lancet editorial states.
DNA repair is essential for cell vitality, cell survival and cancer prevention, yet cells' ability to patch up damaged DNA declines with age for reasons not fully understood.
Ever get a flu shot and still get the flu? If so, there's new hope for flu-free winters in the years to come thanks to a new discovery by researchers who found that a drug called DMXAA, originally developed as anti-tumor agent, enhances the ability of flu vaccines to ward off this deadly virus.
Presage Biosciences, a leader in identifying clinically viable oncology drug combinations, today announced that it has entered into a cancer research agreement with Millennium: The Takeda Oncology Company.
› Verified 3 days ago
| Provider Name | Robert Bryan Freeman |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1548243884 PECOS PAC ID: 0244362598 Enrollment ID: I20200415002692 |
News Archive
"Christoph Benn, director of resource mobilization and donor relations at the Global Fund to Fight AIDS, Tuberculosis and Malaria, updated global health community advocates Wednesday on ... the multilateral organization," the Center for Global Health Policy's "Science Speaks" blog reports.
An "invisible turning point" in the fight against HIV/AIDS recently occurred: "the realisation that simply strengthening the vertical programme that is AIDS has to end. The new opportunity is integration," a Lancet editorial states.
DNA repair is essential for cell vitality, cell survival and cancer prevention, yet cells' ability to patch up damaged DNA declines with age for reasons not fully understood.
Ever get a flu shot and still get the flu? If so, there's new hope for flu-free winters in the years to come thanks to a new discovery by researchers who found that a drug called DMXAA, originally developed as anti-tumor agent, enhances the ability of flu vaccines to ward off this deadly virus.
Presage Biosciences, a leader in identifying clinically viable oncology drug combinations, today announced that it has entered into a cancer research agreement with Millennium: The Takeda Oncology Company.
› Verified 3 days ago
| Provider Name | Deanna Emily Gerowski |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1093329138 PECOS PAC ID: 5890115778 Enrollment ID: I20201014002038 |
News Archive
"Christoph Benn, director of resource mobilization and donor relations at the Global Fund to Fight AIDS, Tuberculosis and Malaria, updated global health community advocates Wednesday on ... the multilateral organization," the Center for Global Health Policy's "Science Speaks" blog reports.
An "invisible turning point" in the fight against HIV/AIDS recently occurred: "the realisation that simply strengthening the vertical programme that is AIDS has to end. The new opportunity is integration," a Lancet editorial states.
DNA repair is essential for cell vitality, cell survival and cancer prevention, yet cells' ability to patch up damaged DNA declines with age for reasons not fully understood.
Ever get a flu shot and still get the flu? If so, there's new hope for flu-free winters in the years to come thanks to a new discovery by researchers who found that a drug called DMXAA, originally developed as anti-tumor agent, enhances the ability of flu vaccines to ward off this deadly virus.
Presage Biosciences, a leader in identifying clinically viable oncology drug combinations, today announced that it has entered into a cancer research agreement with Millennium: The Takeda Oncology Company.
› Verified 3 days ago
News Archive
"Christoph Benn, director of resource mobilization and donor relations at the Global Fund to Fight AIDS, Tuberculosis and Malaria, updated global health community advocates Wednesday on ... the multilateral organization," the Center for Global Health Policy's "Science Speaks" blog reports.
An "invisible turning point" in the fight against HIV/AIDS recently occurred: "the realisation that simply strengthening the vertical programme that is AIDS has to end. The new opportunity is integration," a Lancet editorial states.
DNA repair is essential for cell vitality, cell survival and cancer prevention, yet cells' ability to patch up damaged DNA declines with age for reasons not fully understood.
Ever get a flu shot and still get the flu? If so, there's new hope for flu-free winters in the years to come thanks to a new discovery by researchers who found that a drug called DMXAA, originally developed as anti-tumor agent, enhances the ability of flu vaccines to ward off this deadly virus.
Presage Biosciences, a leader in identifying clinically viable oncology drug combinations, today announced that it has entered into a cancer research agreement with Millennium: The Takeda Oncology Company.
› Verified 3 days ago
Calhoun Quality Health Care Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 601 Leighton Ave, Anniston, AL 36207 Phone: 256-741-9455 | |
Occmed South Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 700 Quintard Ave, Suite B, Anniston, AL 36201 Phone: 256-236-9400 Fax: 256-238-1498 | |
Carla N. Thomas, Md & Linda Dubois, Crnp Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 216 E 8th St, Anniston, AL 36207 Phone: 256-237-0215 Fax: 256-237-0295 | |
Lhm Clinic, P.c. Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 1306 Leighton Ave, Anniston, AL 36207 Phone: 256-236-3031 Fax: 256-236-3202 | |
Keith Patrick Smith Md Llc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 901 Leighton Ave, Ste 705, Anniston, AL 36207 Phone: 256-231-1322 Fax: 256-231-1324 | |
George I Crawford Jr Md Pc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 1105 Woodstock Ave, Anniston, AL 36207 Phone: 256-240-7272 Fax: 256-240-7242 | |
Robert Cater Md Pc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 1425 Greenbrier Dear Rd, Anniston, AL 36207 Phone: 256-770-4327 Fax: 256-770-4309 |